Estimates of wildlife trade for traditional Asian medicine should include that of the caterpillar fungus Ophiocordyceps sinensis (Nature 480, S101–S103; 2011).
The fungus, used to treat asthma and other diseases, is legally harvested on a huge scale in Tibet and the Himalayas, and is one of the world's most expensive natural medical resources. Some 85–185 tonnes are collected annually by the local population for a global market worth between US$5 billion and $11 billion.
Large increases in the price (up by 900% from 1997 to 2008) and trade of caterpillar fungus have encouraged more intensive harvesting. My informal survey of harvesters in the Himalayas reveals that caterpillar fungus abundance is dwindling: the average harvest per collector dropped by around half between 2006 and 2010. Harvesters are extending their range as a result, risking overexploitation of a pristine landscape and more ecosystem degradation.
Conservation efforts must be initiated to halt the decline of this species, which is causing a loss of biodiversity and threatening local livelihoods.
About this article
iTRAQ-based comparative proteome analyses of different growth stages revealing the regulatory role of reactive oxygen species in the fruiting body development of Ophiocordyceps sinensis
Harvest and trade of caterpillar mushroom ( Ophiocordyceps sinensis) and the implications for sustainable use in the Tibet Region of Southwest China
Journal of Ethnopharmacology (2018)
Current Opinion in Insect Science (2015)
Harvesters’ perceptions of population status and conservation of Chinese caterpillar fungus in the Dolpa region of Nepal
Regional Environmental Change (2015)
Economic contribution of Chinese caterpillar fungus to the livelihoods of mountain communities in Nepal
Biological Conservation (2014)